GlassScriptPhysician profile
Stacy A Parker
NPI 1669924452
$547.14
in general payments reported to CMS, 2019-2025
11 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $46.97 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $190.03 | 2025 | Breztri, Airsupra |
| Abbvie INC. | $75.18 | 2025 | |
| Novo Nordisk INC | $55.65 | 2025 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $46.97 | 2022 | |
| Sumitomo Pharma America, INC. | $44.49 | 2025 | Gemtesa |
| Amgen INC. | $33.32 | 2025 | Otezla, Repatha |
| Stryker Corporation | $30.71 | 2025 | Venacore Thrombectomy Catheter |
| Glaxosmithkline, LLC. | $23.48 | 2025 | Trelegy Ellipta |
| Lilly USA, LLC | $22.42 | 2025 | Mounjaro |
| Cranial Technologies, INC | $17.16 | 2025 | Doc Band |
| Phathom Pharmaceuticals, INC. | $7.73 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.